article

1. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis..  Circulation.  149:293-304. 2023
2. Long-term Impact of a 10-Year Intensive Lifestyle Intervention on a Deficit Accumulation Frailty Index: Action for Health in Diabetes Trial..  The journals of gerontology. Series A, Biological sciences and medical sciences.  78:2119-2126. 2023
3. Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure..  Circulation.  147:1121-1133. 2023
4. Role of a Novel Self-Reported Questionnaire for Frailty Assessment in HFpEF..  JACC. Heart failure.  11:404-406. 2023
5. Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart Failure: A Secondary Analysis of a Randomized Clinical Trial..  JAMA cardiology.  8:167-176. 2023
6. Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes - Findings from the Look AHEAD Trial..  The journals of gerontology. Series A, Biological sciences and medical sciences.  77:2489-2497. 2022
7. Sex, lean body mass, and cardiac performance..  Science translational medicine.  14:-. 2022
8. Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the ASPC Part I: Bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations..  American journal of preventive cardiology.  -. 2022
9. Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations..  American journal of preventive cardiology.  -. 2022
10. Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies..  JACC. Heart failure.  10:583-594. 2022
11. Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study..  JACC. Heart failure.  10:485-493. 2022
12. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults..  Journal of cardiac failure.  29:6-15. 2022
13. Exerkines in health, resilience and disease..  Nature reviews. Endocrinology.  18:273-289. 2022
14. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial..  JACC. Heart failure.  10:266-275. 2022
15. Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials..  Progress in cardiovascular diseases.  48-55. 2022
16. Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric..  Journal of the American College of Cardiology.  79:132-144. 2022
17. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults..  JACC. Heart failure.  10:129-138. 2021
18. Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts..  Circulation.  145:268-278. 2021
19. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia..  European journal of heart failure.  24:169-180. 2021
20. Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction..  JACC. Basic to translational science.  6:918-932. 2021
21. Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices..  The American journal of cardiology.  93-99. 2021
22. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries..  Journal of the American Heart Association.  10:-. 2021
23. Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries..  Circulation.  145:110-121. 2021
24. Longitudinal Trajectories and Factors Associated With US County-Level Cardiovascular Mortality, 1980 to 2014..  JAMA network open.  4:-. 2021
25. Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance..  Circulation. Heart failure.  14:-. 2021
26. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)..  Biomarkers in medicine.  15:1487-1498. 2021
27. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults..  Journal of the American College of Cardiology.  78:1587-1598. 2021
28. Physical Activity and Cardiorespiratory Fitness: Vital Signs for Cardiovascular Risk Assessment..  Current cardiology reports.  23:-. 2021
29. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population..  Journal of cardiac failure.  28:403-414. 2021
30. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018..  American heart journal.  103-109. 2021
31. Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes..  Journal of the American College of Cardiology.  78:1242-1253. 2021
32. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review..  Journal of the American College of Cardiology.  78:1166-1187. 2021
33. Beyond Physical Impairment: The Role of Social Frailty in Heart Failure..  Journal of the American Heart Association.  10:-. 2021
34. Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)..  The American journal of cardiology.  59-65. 2021
35. Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease..  American heart journal.  45-60. 2021
36. Discordance Between Severity of Heart Failure as Determined by Patient Report Versus Cardiopulmonary Exercise Testing..  Journal of the American Heart Association.  10:-. 2021
37. Physical frailty in older patients with acute heart failure: From risk marker to modifiable treatment target..  Journal of the American Geriatrics Society.  69:2451-2454. 2021
38. Regional adiposity, cardiorespiratory fitness, and left ventricular strain: an analysis from the Dallas Heart Study..  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.  23:-. 2021
39. Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults..  JACC. Heart failure.  9:484-493. 2021
40. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels..  JAMA cardiology.  6:690-696. 2021
41. Prefrailty, impairment in physical function, and risk of incident heart failure among older adults..  Journal of the American Geriatrics Society.  69:2486-2497. 2021
42. Targeting the nitrate-nitrite-nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?.  European journal of heart failure.  23:824-825. 2021
43. Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)..  JAMA cardiology.  6:388-398. 2021
44. Longitudinal Associations of Fitness and Obesity in Young Adulthood With Right Ventricular Function and Pulmonary Artery Systolic Pressure in Middle Age: The CARDIA Study..  Journal of the American Heart Association.  10:-. 2021
45. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes..  Diabetologia.  64:1583-1594. 2021
46. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems..  ESC heart failure.  8:2089-2102. 2021
47. Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled Cohort Analysis..  Hypertension (Dallas, Tex. : 1979).  77:1106-1118. 2021
48. Cross-Sectional Associations of Objectively Measured Sedentary Time, Physical Activity, and Fitness With Cardiac Structure and Function: Findings From the Dallas Heart Study..  Journal of the American Heart Association.  10:-. 2021
49. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT..  ESC heart failure.  8:842-848. 2021
50. U.S. population at increased risk of severe illness from COVID-19..  American journal of preventive cardiology.  -. 2021
51. Searching for the Optimal Exercise Training Regimen in Heart Failure With Preserved Ejection Fraction..  JAMA.  325:537-539. 2021
52. Evaluation of Risk-Adjusted Home Time After Hospitalization for Heart Failure as a Potential Hospital Performance Metric..  JAMA cardiology.  6:169-176. 2021
53. Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply..  Mayo Clinic proceedings.  96:503-506. 2021
54. Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes..  JACC. Heart failure.  9:215-223. 2021
55. Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction..  Journal of the American Geriatrics Society.  69:1309-1318. 2021
56. Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In-Hospital-Onset Versus Out-of-Hospital Onset: The ARIC Study..  Journal of the American Heart Association.  10:-. 2021
57. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction..  JAMA cardiology.  6:68-77. 2021
58. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database..  JAMA cardiology.  6:92-96. 2021
59. Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study..  JACC. CardioOncology.  2:710-718. 2020
60. Gender-Based Differences in Outcomes Among Resuscitated Patients With Out-of-Hospital Cardiac Arrest..  Circulation.  143:641-649. 2020
61. Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study..  JACC. Heart failure.  9:179-189. 2020
62. Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes..  Progress in cardiovascular diseases.  63:762-774. 2020
63. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial..  Circulation.  142:2420-2430. 2020
64. Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018..  Circulation. Cardiovascular quality and outcomes.  14:-. 2020
65. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016..  JAMA network open.  3:-. 2020
66. Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure..  Progress in cardiovascular diseases.  63:649-655. 2020
67. Medicaid Expansion and Utilization of Antihyperglycemic Therapies..  Diabetes care.  43:2684-2690. 2020
68. Predictive Value of Coronary Artery Calcium Score Categories for Coronary Events Versus Strokes: Impact of Sex and Race: MESA and DHS..  Circulation. Cardiovascular imaging.  13:-. 2020
69. Long-term predictive value of stroke volume index obtained from right heart catheterization: Insights from the veterans affairs clinical assessment, reporting, and tracking program..  Clinical cardiology.  43:1126-1132. 2020
70. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial..  Diabetes care.  43:1920-1928. 2020
71. Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance..  Circulation.  142:230-243. 2020
72. Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries..  Circulation.  142:29-39. 2020
73. Preventing Heart Failure With Habitual Physical Activity: Dependence on Heart Failure Phenotype and Concomitant Cardiovascular Disease..  Journal of the American Heart Association.  9:-. 2020
74. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial..  Circulation.  141:1295-1306. 2020
75. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure..  JAMA cardiology.  5:336-339. 2020
76. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries..  JAMA network open.  3:-. 2020
77. Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306..  Diabetes care.  43:e26-e27. 2020
78. Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries..  JAMA cardiology.  5:136-145. 2020
79. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study..  Circulation.  141:957-967. 2020
80. Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA..  European heart journal. Quality of care & clinical outcomes.  6:62-71. 2020
81. Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017..  JAMA internal medicine.  180:141-144. 2020
82. Towards global improvement in heart failure care..  European journal of heart failure.  22:661-663. 2019
83. Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods..  JACC. Heart failure.  7:1079-1088. 2019
84. Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management..  JACC. Heart failure.  7:1001-1011. 2019
85. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis..  Circulation.  140:2076-2088. 2019
86. Healthy Aging and Cardiovascular Function: Invasive Hemodynamics During Rest and Exercise in 104 Healthy Volunteers..  JACC. Heart failure.  8:111-121. 2019
87. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis..  European journal of heart failure.  22:148-158. 2019
88. Short-Term Changes in Cardiorespiratory Fitness in Response to Exercise Training and the Association with Long-Term Cardiorespiratory Fitness Decline: The STRRIDE Reunion Study..  Journal of the American Heart Association.  8:-. 2019
89. Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy..  JACC. CardioOncology.  1:54-65. 2019
90. Association of Long-Term Risk Factor Levels With Carotid Atherosclerosis: The Chicago Healthy Aging Magnetic Resonance Imaging Plaque Study (CHAMPS)..  Circulation. Cardiovascular imaging.  12:-. 2019
91. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score..  Diabetes care.  42:2298-2306. 2019
92. Rapid-Cycle Implementation of a Multi-Organization Registry for Heart Failure with Preserved Ejection Fraction Using Health Information Exchange Standards..  Studies in health technology and informatics.  1560-1561. 2019
93. Sex differences in cardiac function, biomarkers and exercise performance in heart failure with preserved ejection fraction: findings from the RELAX trial..  European journal of heart failure.  21:1476-1479. 2019
94. Taking a Day Off in the Care of Patients With Acute Decompensated Heart Failure: The Weekend Effect..  Journal of the American Heart Association.  8:-. 2019
95. Trends and causes of hospitalizations in patients with amyloidosis..  Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.  26:177-178. 2019
96. Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus..  Diabetes care.  42:1333-1339. 2019
97. Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week..  Journal of the American College of Cardiology.  73:2454-2464. 2019
98. Implications of Perceived Dyspnea and Global Well-Being Measured by Visual Assessment Scales During Treatment for Acute Decompensated Heart Failure..  The American journal of cardiology.  124:402-408. 2019
99. Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline..  Mayo Clinic proceedings.  94:776-782. 2019
100. Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial..  ESC heart failure.  6:613-620. 2019
101. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program..  JAMA network open.  2:-. 2019
102. Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial..  European journal of heart failure.  21:693-695. 2019
103. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association..  Circulation.  139:e56-e528. 2019
104. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction..  Circulation.  139:1047-1056. 2019
105. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT..  European journal of heart failure.  21:634-642. 2019
106. Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials..  Mayo Clinic proceedings.  94:211-224. 2019
107. Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)..  The American journal of medicine.  132:733-739. 2019
108. Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study..  JAMA cardiology.  4:51-58. 2019
109. Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency..  Hypertension (Dallas, Tex. : 1979).  73:60-67. 2019
110. Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction..  JACC. Heart failure.  6:975-982. 2018
111. Managing Implantable Cardioverter-Defibrillators at End-of-Life: Practical Challenges and Care Considerations..  The American journal of the medical sciences.  357:143-150. 2018
112. Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial..  Journal of the American Heart Association.  7:-. 2018
113. Association Between Regional Adipose Tissue Distribution and Risk of Heart Failure Among Blacks..  Circulation. Heart failure.  11:-. 2018
114. Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial..  Resuscitation.  69-75. 2018
115. Trends in Inpatient Complications After Transcatheter and Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era..  Circulation. Cardiovascular interventions.  11:-. 2018
116. Developing evidence-based and accountable health policy in heart failure..  European journal of heart failure.  20:1653-1656. 2018
117. Predicting and Preventing Hospital Readmissions in Value-Based Programs..  Circulation. Cardiovascular quality and outcomes.  11:-. 2018
118. Promoting High-Value Change by Addressing the Structure of Order Sets: Lessons From the Cardiac Catheterization Lab..  American journal of medical quality : the official journal of the American College of Medical Quality.  34:-. 2018
119. Seasonal and Geographic Patterns in Seeking Cardiovascular Health Information: An Analysis of the Online Search Trends..  Mayo Clinic proceedings.  93:1185-1190. 2018
120. Errors Resulting From Standard Order Sets-In Reply..  JAMA.  320:-. 2018
121. Vitamin D Status and Exercise Capacity in Older Patients with Heart Failure with Preserved Ejection Fraction..  The American journal of medicine.  131:1515.e11-1515.e19. 2018
122. The Reply..  The American journal of medicine.  131:e389-e390. 2018
123. The Emerging Role of Mobile-Health Applications in the Management of Hypertension..  Current cardiology reports.  20:-. 2018
124. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases..  Progress in cardiovascular diseases.  61:142-150. 2018
125. Prognostic implications of microvascular complications in patients with diabetes and heart failure with reduced ejection fraction..  European journal of heart failure.  20:1557-1558. 2018
126. Highlights From the American Heart Association's EPI|LIFESTYLE 2018 Scientific Sessions..  Journal of the American Heart Association.  7. 2018
127. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT..  European journal of heart failure.  20:1436-1443. 2018
128. Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry..  JAMA cardiology.  3:489-497. 2018
129. Obesity, Central Adiposity, and Fitness: Understanding the Obesity Paradox in the Context of Other Cardiometabolic Parameters..  Mayo Clinic proceedings.  93:676-678. 2018
130. The Reply..  The American journal of medicine.  131:-. 2018
131. The Reply..  The American journal of medicine.  131:e267-e268. 2018
132. Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine..  Circulation.  137:2551-2553. 2018
133. The Evolving Role of Cardiorespiratory Fitness and Exercise in Prevention and Management of Heart Failure..  Current heart failure reports.  15:75-80. 2018
134. β-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets..  JAMA.  319:1269-1270. 2018
135. Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT..  The American journal of medicine.  131:956-960. 2018
136. Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis..  JACC. Heart failure.  6:117-126. 2018
137. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association..  Circulation.  137:e67-e492. 2018
138. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction..  Circulation.  137:1814-1823. 2018
139. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis..  Gastroenterology.  154:1309-1319.e7. 2018
140. Editorial commentary: Obesity and heart failure with preserved ejection fraction: A single disease or two co-existing conditions?.  Trends in cardiovascular medicine.  28:328-329. 2017
141. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials..  The American journal of medicine.  131:575-577. 2017
142. Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States..  JAMA cardiology.  2:1322-1331. 2017
143. The heart failure readmission quagmire: taking a deep dive to find solutions..  European journal of heart failure.  20:315-316. 2017
144. Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings..  Circulation. Heart failure.  10. 2017
145. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis..  European heart journal.  38:3082-3089. 2017
146. Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Chronic Kidney Disease..  The American journal of cardiology.  121:343-348. 2017
147. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise..  Journal of the American College of Cardiology.  70:2022-2035. 2017
148. Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study..  Circulation.  136:1451-1453. 2017
149. Physical Activity in Heart Failure With Preserved Ejection Fraction: Moving Toward a Newer Treatment Paradigm..  Circulation.  136:993-995. 2017
150. Comparison of Readmission Rates After Acute Myocardial Infarction in 3 Patient Age Groups (18 to 44, 45 to 64, and ≥65 Years) in the United States..  The American journal of cardiology.  120:1761-1767. 2017
151. Association of Concentric Left Ventricular Hypertrophy With Subsequent Change in Left Ventricular End-Diastolic Volume: The Dallas Heart Study..  Circulation. Heart failure.  10. 2017
152. Relationship of Cardiorespiratory Fitness and Adiposity With Left Ventricular Strain in Middle-Age Adults (from the Dallas Heart Study)..  The American journal of cardiology.  120:1405-1409. 2017
153. Exercise Training for Prevention and Treatment of Heart Failure..  Progress in cardiovascular diseases.  60:115-120. 2017
154. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines..  JAMA cardiology.  2:723-731. 2017
155. Invited Commentary: Searching for the Perfect Measure of Diastolic Dysfunction-A Futile Exercise?.  American journal of epidemiology.  185:1228-1230. 2017
156. The Interaction of Cardiorespiratory Fitness With Obesity and the Obesity Paradox in Cardiovascular Disease..  Progress in cardiovascular diseases.  60:30-44. 2017
157. Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials..  JACC. Cardiovascular interventions.  10:712-724. 2017
158. Body Mass Index and Cardiorespiratory Fitness in Mid-Life and Risk of Heart Failure Hospitalization in Older Age: Findings From the Cooper Center Longitudinal Study..  JACC. Heart failure.  5:367-374. 2017
159. Response to Endurance Exercise Training in Older Adults with Heart Failure with Preserved or Reduced Ejection Fraction..  Journal of the American Geriatrics Society.  65:1698-1704. 2017
160. Pericardial Fat and CVD: Is All Fat Created Equally?.  JACC. Cardiovascular imaging.  10:1028-1030. 2017
161. An Analysis of Individual Body Fat Depots and Risk of Developing Cancer: Insights From the Dallas Heart Study..  Mayo Clinic proceedings.  92:536-543. 2017
162. Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study..  JACC. Heart failure.  5:347-355. 2017
163. Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure..  Journal of the American College of Cardiology.  69:1129-1142. 2017
164. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..  JAMA cardiology.  2:136-145. 2017
165. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation..  JACC. Heart failure.  5:44-52. 2017
166. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition)..  Hypertension (Dallas, Tex. : 1979).  69:267-274. 2016
167. Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes..  JACC. Heart failure.  4:935-946. 2016
168. Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States..  Circulation. Heart failure.  9. 2016
169. Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis..  JACC. Clinical electrophysiology.  3:117-126. 2016
170. Heparin Versus Bivalirudin in ST-Segment Elevation Myocardial Infarction: A SCAI-Based National Survey From US Interventional Cardiologists..  The Journal of invasive cardiology.  28:351-6. 2016
171. Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: A Meta-analysis..  JAMA cardiology.  1:575-83. 2016
172. Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study..  Stroke.  47:1720-6. 2016
173. Determinants of Racial/Ethnic Differences in Cardiorespiratory Fitness (from the Dallas Heart Study)..  The American journal of cardiology.  118:499-503. 2016
174. Racial Differences in Outcomes after Acute Ischemic Stroke Hospitalization in the United States..  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.  25:1970-7. 2016
175. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..  JACC. Heart failure.  4:649-61. 2016
176. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG)..  Circulation. Cardiovascular quality and outcomes.  9:197-205. 2016
177. Drug-Induced Torsades de Pointes and Genetic Screening--Reply..  JAMA internal medicine.  176:-. 2016
178. Transcatheter Aortic Valve Replacement Complication Rates in Teaching Vs Non-Teaching Centers in the United States..  The Journal of invasive cardiology.  28:67-70. 2016
179. Use of Pulmonary Artery Catheterization in US Patients With Heart Failure, 2001-2012..  JAMA internal medicine.  176:129-32. 2016
180. Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus..  Diabetes & vascular disease research.  13:113-8. 2015
181. Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry..  JACC. Clinical electrophysiology.  2:355-363. 2015
182. Inappropriate Antibiotic Therapy in a Patient With Heart Failure and Prolonged QT Interval: A Teachable Moment..  JAMA internal medicine.  175:1748-9. 2015
183. Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review..  Journal of the American Heart Association.  4:-. 2015
184. Dose-Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis..  Circulation.  132:1786-94. 2015
185. Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy..  Current heart failure reports.  12:302-8. 2015
186. Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry..  Journal of the American College of Cardiology.  66:917-26. 2015
187. Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population..  JACC. Cardiovascular imaging.  8:1034-1041. 2015
188. Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis..  Circulation. Heart failure.  8:1032-43. 2015
189. Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study..  Diabetes care.  38:1494-501. 2015
190. Low Fitness in Midlife: A Novel Therapeutic Target for Heart Failure with Preserved Ejection Fraction Prevention..  Progress in cardiovascular diseases.  58:87-93. 2015
191. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension..  Journal of the American Society of Hypertension : JASH.  9:420-426.e2. 2015
192. Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension..  Journal of clinical hypertension (Greenwich, Conn.).  17:713-9. 2015
193. Cardiac determinants of heterogeneity in fitness change in response to moderate intensity aerobic exercise training: the DREW study..  Journal of the American College of Cardiology.  65:1057-8. 2015
194. Effect of preoperative angina pectoris on cardiac outcomes in patients with previous myocardial infarction undergoing major noncardiac surgery (data from ACS-NSQIP)..  The American journal of cardiology.  115:1080-4. 2015
195. An unusual rash in a middle-aged man..  Journal of general internal medicine.  29:1711-2. 2014
196. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials..  Circulation. Heart failure.  8:33-40. 2014
197. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study..  American heart journal.  169:290-297.e1. 2014
198. Predictors of coronary artery disease in patients with Behçet's disease..  Cardiology.  129:203-6. 2014
199. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery..  Nanotechnology.  25:-. 2014
200. Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study..  JACC. Heart failure.  2:238-46. 2014
201. Perceived lifetime risk for cardiovascular disease (from the Dallas Heart Study)..  The American journal of cardiology.  114:53-8. 2014
202. Impact of Vice President Cheney on public interest in left ventricular assist devices and heart transplantation..  The American journal of cardiology.  113:1529-31. 2014
203. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension..  Journal of the American College of Cardiology.  63:834-5. 2013
204. Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy..  Cancer research.  74:675-685. 2013
205. Physical fitness and risk for heart failure and coronary artery disease..  Circulation. Heart failure.  6:627-34. 2013
206. P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer..  Medical oncology (Northwood, London, England).  30:-. 2013
207. Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior..  Journal of cancer education : the official journal of the American Association for Cancer Education.  28:138-42. 2013
208. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity..  Proceedings of the National Academy of Sciences of the United States of America.  109:11294-9. 2012
209. Endoscopic retrograde cholangiopancreatography complications in the era of cholangioscopy: is there an increased risk?.  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.  44:754-8. 2012
210. Insulin-like growth factors promote vasculogenesis in embryonic stem cells..  PloS one.  7:-. 2012
211. YouTube as a source of information on the H1N1 influenza pandemic..  American journal of preventive medicine.  38:e1-3. 2010
212. Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India..  Tobacco induced diseases.  5:-. 2009
213. Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1..  Medical oncology (Northwood, London, England).  27:1096-101. 2009
214. Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country..  Vascular health and risk management.  643-8. 2009
215. Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus..  Glycoconjugate journal.  26:721-32. 2008
216. Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of Paclitaxel and sirolimus eluting stents..  Current drug metabolism.  9:554-66. 2008
217. Unilateral diaphragm paralysis: etiology, impact, and natural history..  The Journal of cardiovascular surgery.  49:289-95. 2008
218. The Yin and Yang of lactosylceramide metabolism: implications in cell function..  Biochimica et biophysica acta.  1780:370-82. 2007